Ontology type: schema:ScholarlyArticle
2016-11-29
AUTHORSYosuke Hirotsu, Hiroshi Nakagomi, Kenji Amemiya, Toshio Oyama, Masayuki Inoue, Hitoshi Mochizuki, Masao Omata
ABSTRACTHER2 (ERBB2) is an oncogene and 20% of breast cancers display HER2 amplification. The HER2 monoclonal antibody, trastuzumab, is used to treat breast cancers that display HER2 amplification, with good responses in 80–90% of cases; however, 10% of tumours develop resistance to trastuzumab. In this study, we collected data of primary breast cancer patients who treated at hospital during 2004–2014. In our cohort, 205 of 1497 primary breast cancer patients showed HER2-amplification, and 20 experienced recurrence after trastuzumab therapy. Of the 20 recurrent cases, only six patients had metastatic sites, excluding brain metastases, which were resistant to trastuzumab. To examine trastuzumab resistance in HER2-amplified breast cancer, we analysed clinical specimens before and after trastuzumab therapy. The results indicated that an intrinsic activating mutation leads to a valine-to-leucine substitution at codon 777 within the HER2 kinase domain (HER2 V777L). This was identified in one of six cases of a HER2-amplified breast cancer, both pre- and post-treatment; however, HER2 V777L was not identified in 14 responders who were treated with trastuzumab. These results suggest that HER2 V777L mutation is responsible for, and a predictive marker of, trastuzumab resistance. This is the first report to show that HER2 V777L is coincident with HER2-amplification in breast cancers that have developed trastuzumab resistance. More... »
PAGES3
http://scigraph.springernature.com/pub.10.1007/s12032-016-0857-2
DOIhttp://dx.doi.org/10.1007/s12032-016-0857-2
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1005513585
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/27900589
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Breast Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Resistance, Neoplasm",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptor, ErbB-2",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Trastuzumab",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Genome Analysis Center, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan",
"id": "http://www.grid.ac/institutes/grid.417333.1",
"name": [
"Genome Analysis Center, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
],
"type": "Organization"
},
"familyName": "Hirotsu",
"givenName": "Yosuke",
"id": "sg:person.01104463136.69",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104463136.69"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Breast Surgery, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan",
"id": "http://www.grid.ac/institutes/grid.417333.1",
"name": [
"Department of Breast Surgery, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
],
"type": "Organization"
},
"familyName": "Nakagomi",
"givenName": "Hiroshi",
"id": "sg:person.01152576336.53",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152576336.53"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Pathology Division, Laboratory Department, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan",
"id": "http://www.grid.ac/institutes/grid.417333.1",
"name": [
"Genome Analysis Center, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan",
"Pathology Division, Laboratory Department, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
],
"type": "Organization"
},
"familyName": "Amemiya",
"givenName": "Kenji",
"id": "sg:person.01271466715.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271466715.07"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Pathology Division, Laboratory Department, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan",
"id": "http://www.grid.ac/institutes/grid.417333.1",
"name": [
"Pathology Division, Laboratory Department, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
],
"type": "Organization"
},
"familyName": "Oyama",
"givenName": "Toshio",
"id": "sg:person.011405362052.18",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011405362052.18"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Breast Surgery, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan",
"id": "http://www.grid.ac/institutes/grid.417333.1",
"name": [
"Department of Breast Surgery, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
],
"type": "Organization"
},
"familyName": "Inoue",
"givenName": "Masayuki",
"id": "sg:person.01354217107.78",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354217107.78"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan",
"id": "http://www.grid.ac/institutes/grid.417333.1",
"name": [
"Genome Analysis Center, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan",
"Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
],
"type": "Organization"
},
"familyName": "Mochizuki",
"givenName": "Hitoshi",
"id": "sg:person.01335140136.50",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335140136.50"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.26999.3d",
"name": [
"Genome Analysis Center, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan",
"Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan",
"The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Omata",
"givenName": "Masao",
"id": "sg:person.0775700471.08",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775700471.08"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/ng.2822",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019741899",
"https://doi.org/10.1038/ng.2822"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12032-016-0744-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051585301",
"https://doi.org/10.1007/s12032-016-0744-x"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/ng.2823",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010741940",
"https://doi.org/10.1038/ng.2823"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/ncomms9760",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031101673",
"https://doi.org/10.1038/ncomms9760"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/ng.3037",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020182683",
"https://doi.org/10.1038/ng.3037"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature11412",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024942368",
"https://doi.org/10.1038/nature11412"
],
"type": "CreativeWork"
}
],
"datePublished": "2016-11-29",
"datePublishedReg": "2016-11-29",
"description": "HER2 (ERBB2) is an oncogene and 20% of breast cancers display HER2 amplification. The HER2 monoclonal antibody, trastuzumab, is used to treat breast cancers that display HER2 amplification, with good responses in 80\u201390% of cases; however, 10% of tumours develop resistance to trastuzumab. In this study, we collected data of primary breast cancer patients who treated at hospital during 2004\u20132014. In our cohort, 205 of 1497 primary breast cancer patients showed HER2-amplification, and 20 experienced recurrence after trastuzumab therapy. Of the 20 recurrent cases, only six patients had metastatic sites, excluding brain metastases, which were resistant to trastuzumab. To examine trastuzumab resistance in HER2-amplified breast cancer, we analysed clinical specimens before and after trastuzumab therapy. The results indicated that an intrinsic activating mutation leads to a valine-to-leucine substitution at codon 777 within the HER2 kinase domain (HER2 V777L). This was identified in one of six cases of a HER2-amplified breast cancer, both pre- and post-treatment; however, HER2 V777L was not identified in 14 responders who were treated with trastuzumab. These results suggest that HER2 V777L mutation is responsible for, and a predictive marker of, trastuzumab resistance. This is the first report to show that HER2 V777L is coincident with HER2-amplification in breast cancers that have developed trastuzumab resistance.",
"genre": "article",
"id": "sg:pub.10.1007/s12032-016-0857-2",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1094524",
"issn": [
"1357-0560",
"1559-131X"
],
"name": "Medical Oncology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "34"
}
],
"keywords": [
"breast cancer patients",
"primary breast cancer patients",
"breast cancer",
"trastuzumab resistance",
"cancer patients",
"trastuzumab therapy",
"HER2 amplification",
"HER2 monoclonal antibody",
"brain metastases",
"metastatic sites",
"HER2 kinase domain",
"predictive marker",
"recurrent cases",
"trastuzumab",
"patients",
"clinical specimens",
"cancer",
"monoclonal antibodies",
"HER2",
"V777L",
"good response",
"therapy",
"first report",
"mutations",
"recurrence",
"metastasis",
"leucine substitution",
"hospital",
"tumors",
"cohort",
"responders",
"cases",
"antibodies",
"resistance",
"kinase domain",
"markers",
"oncogene",
"report",
"amplification",
"response",
"study",
"valine",
"specimens",
"results",
"data",
"sites",
"substitution",
"domain"
],
"name": "Intrinsic HER2 V777L mutation mediates resistance to trastuzumab in a breast cancer patient",
"pagination": "3",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1005513585"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s12032-016-0857-2"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"27900589"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s12032-016-0857-2",
"https://app.dimensions.ai/details/publication/pub.1005513585"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-10T10:13",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_720.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s12032-016-0857-2"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12032-016-0857-2'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12032-016-0857-2'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12032-016-0857-2'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12032-016-0857-2'
This table displays all metadata directly associated to this object as RDF triples.
215 TRIPLES
22 PREDICATES
87 URIs
73 LITERALS
14 BLANK NODES